Filing Details

Accession Number:
0001179929-15-000073
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-18 16:58:19
Reporting Period:
2015-05-15
Filing Date:
2015-05-18
Accepted Time:
2015-05-18 16:58:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1179929 Molina Healthcare Inc MOH Hospital & Medical Service Plans (6324) 134204626
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1305822 Terry Bayer 300 University Avenue, Suite 100
Sacramento CA 95825
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-05-15 21,000 $19.11 153,714 No 4 M Direct
Common Stock Disposition 2015-05-15 21,000 $69.01 132,714 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2015-05-15 21,000 $0.00 21,000 $19.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-02-02 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (Right to Buy) $20.88 2017-03-01 16,500 16,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2017-03-01 16,500 16,500 Direct
Footnotes
  1. The transaction was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on March 13, 2015.
  2. Represents the exercise price per share.
  3. Represents the weighted average selling price with a selling price range between $68.23 and $69.74.
  4. The shares vest as follows: (i) 2,865 shares shall vest based on the Company's fiscal year 2016 annual premium revenue achievement; (ii) 2,865 shares shall vest based on the Company's fiscal year 2016 net profit margin achievement; (iii) 2,865 shares shall vest based on the Company's pre-tax income in fiscal year 2016; (iv) 2,865 shares shall vest based on the Company's 2017 annual premium revenue achievement; (v) 2,865 shares shall vest based on the Company's 2017 net profit margin achievement; continued
  5. (vi) 2,865 shares shall vest based on pre-tax income in fiscal year 2017; (vii) 2,865 shares shall vest upon the Company's achieving a three-year Total Stockholder Return (TSR) for the three-year period ending December 31, 2017 as determined by ISS calculations that is greater than the median TSR achieved by the Company's 2015 ISS peer group; and (viii) 8,599 shares shall vest in one-third increments over three years, on each of April 1, 2016, April 1, 2017, and April 1, 2018. See 2015 Definitive Proxy Statement.
  6. Additional vesting as follows: (ix) 15,572 shares shall vest upon the Company achieving total revenue in any of the 2013, 2014, or 2015 fiscal years equal to or greater than $12 billion; (x) 4,644 shares shall vest upon the Company achieving three-year TSR as determined by ISS calculations that is greater than the median TSR achieved by the Company's ISS peer group for the three-year period ending December 31, 2016; continued
  7. (xi) 11,611 shares shall vest upon the Company achieving a three-year EBITDA margin percentage for the three-year period ending December 31, 2016 equal to or greater than 4.0%; (xii) 11,611 of shares shall vest upon the Company achieving a cumulative earnings per share of at least $8.50 for the three year period ending December 31, 2016; (xii) 9,836 shares vest on March 1, 2016; and (xiv) 4,644 shares vest on March 1, 2017. The remainder of the shares are vested.
  8. The options are fully vested.